Literature DB >> 33694101

[Guidelines for ophthalmological screening of premature infants in Germany (S2k level, AWMF guidelines register no. 024/010, March 2020) : Joint recommendation of the German Ophthalmological Society (DOG), Retinological Society (RG), Professional Association of Ophthalmologists in Germany e. V. (BVA), German Society of Paediatrics and Adolescent Medicine (DGKJ), Professional Association of Pediatricians (BVKJ), Federal Association "The Premature Child" , Society for Neonatology and Paediatric Intensive Care Medicine (GNPI)].

Rolf F Maier1, Helmut Hummler2, Ulrich Kellner3, Tim U Krohne4, Burkhard Lawrenz5, Birgit Lorenz6, Barbara Mitschdörfer7, Claudia Roll8, Andreas Stahl9.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33694101     DOI： 10.1007/s00347-021-01353-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  74 in total

1.  [Ophthalmological screening studies in newborn infants. German Ophthalmological Society].

Authors:  S Clemens; C Eckardt; H Gerding; A Grote; C Jandeck; U Kellner; B Lorenz; J Petersen; V Seiberth; N Stärk; M W Ulbig; A Zubcov; G Jorch; F Pohlandt
Journal:  Ophthalmologe       Date:  1999-04       Impact factor: 1.059

Review 2.  Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.

Authors:  Richard Pugh; Chris Grant; Richard Pd Cooke; Ged Dempsey
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

3.  Urinary N-terminal B-type natriuretic peptide predicts severe retinopathy of prematurity.

Authors:  Christoph Czernik; Boris Metze; Christian Müller; Bert Müller; Christoph Bührer
Journal:  Pediatrics       Date:  2011-08-08       Impact factor: 7.124

4.  A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome.

Authors:  Brian P Connolly; Eugene Y J Ng; J Arch McNamara; Carl D Regillo; James F Vander; William Tasman
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

5.  The influence of fish-oil lipid emulsions on retinopathy of prematurity in very low birth weight infants: a randomized controlled trial.

Authors:  Serdar Beken; Dilek Dilli; Nurdan Dinlen Fettah; Emrah Utku Kabataş; Ayşegül Zenciroğlu; Nurullah Okumuş
Journal:  Early Hum Dev       Date:  2013-12-04       Impact factor: 2.079

6.  Plus Disease in Retinopathy of Prematurity: A Continuous Spectrum of Vascular Abnormality as a Basis of Diagnostic Variability.

Authors:  J Peter Campbell; Jayashree Kalpathy-Cramer; Deniz Erdogmus; Peng Tian; Dharanish Kedarisetti; Chace Moleta; James D Reynolds; Kelly Hutcheson; Michael J Shapiro; Michael X Repka; Philip Ferrone; Kimberly Drenser; Jason Horowitz; Kemal Sonmez; Ryan Swan; Susan Ostmo; Karyn E Jonas; R V Paul Chan; Michael F Chiang
Journal:  Ophthalmology       Date:  2016-08-31       Impact factor: 12.079

7.  A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity.

Authors:  Juliann M Di Fiore; Jeffrey N Bloom; Faruk Orge; Alison Schutt; Mark Schluchter; Vinay K Cheruvu; Michele Walsh; Neil Finer; Richard J Martin
Journal:  J Pediatr       Date:  2010-03-20       Impact factor: 4.406

8.  Intravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between Ranibizumab and Bevacizumab.

Authors:  San-Ni Chen; Iebin Lian; Ya-Chi Hwang; Yi-Hsing Chen; Yao-Chung Chang; Kun-Hsien Lee; Chih-Chun Chuang; Wei-Chi Wu
Journal:  Retina       Date:  2015-04       Impact factor: 4.256

9.  Systemic fungal infection is associated with the development of retinopathy of prematurity in very low birth weight infants: a meta-review.

Authors:  S K Bharwani; R Dhanireddy
Journal:  J Perinatol       Date:  2007-11-29       Impact factor: 2.521

10.  Low-dose ranibizumab as primary treatment of posterior type I retinopathy of prematurity.

Authors:  Anna L Ells; Jason D Wesolosky; April D Ingram; Patrick C Mitchell; Alexander S Platt
Journal:  Can J Ophthalmol       Date:  2017-07-19       Impact factor: 1.882
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.